| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P2093 | author name string | McNeil HP | |
| Visvanathan S | |||
| Geczy CL | |||
| Harmer JA | |||
| P2860 | cites work | Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) | Q24558202 |
| Immunology and Clinical Importance of Antiphospholipid Antibodies | Q33379907 | ||
| Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression | Q33499291 | ||
| Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. | Q36709354 | ||
| Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies | Q40651854 | ||
| Cellular mechanisms for the activation of blood coagulation. | Q40764557 | ||
| Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? | Q40841827 | ||
| Immunology of the antiphospholipid antibody syndrome | Q41116413 | ||
| Th1-type immunity is incompatible with successful pregnancy | Q41632972 | ||
| Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis | Q48394757 | ||
| New Fluorogenic Substrates for α-Thrombin, Factor Xa, Kallikreins, and Urokinase1 | Q54592695 | ||
| Delayed Hypersensitivity in Man: Effects of Systemic Anticoagulation | Q67321924 | ||
| Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus | Q68008000 | ||
| The management of thrombosis in the antiphospholipid-antibody syndrome | Q72619159 | ||
| Antibodies to beta2-glycoprotein I--a specific marker for the antiphospholipid syndrome | Q73641569 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| thrombosis | Q261327 | ||
| P304 | page(s) | 2258-2262 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Monocyte tissue factor induction by activation of beta 2-glycoprotein-I-specific T lymphocytes is associated with thrombosis and fetal loss in patients with antiphospholipid antibodies | |
| P478 | volume | 165 |
| Q34354736 | Accelerated atheroma, antiphospholipid antibodies, and the antiphospholipid syndrome |
| Q74459320 | Autoreactive CD4(+) T-cell clones to beta2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site |
| Q44461543 | Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression |
| Q34372303 | Beta2-glycoprotein I and atherosclerosis |
| Q35928650 | Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity |
| Q81459713 | Clinical manifestations of chronic inflammatory demyelinating polyneuropathy with anti-cardiolipin antibodies |
| Q74410177 | Letter of retraction. "Monocyte tissue factor induction by activation of beta 2-glycoprotein-I-specific T lymphocytes is associated with thrombosis and fetal loss in patients with antiphospholipid antibodies", The Journal of Immunology 2000;165:2258 |
| Q35013236 | Modern concept on the role of phagocytes in the pathogenesis of complications during pregnancy |
| Q34489999 | Molecular pathogenesis of the antiphospholipid syndrome |
| Q34404108 | Pathogenic mechanisms mediating antiphospholipid syndrome |
| Q33357759 | Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome |
| Q47442034 | Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I. |
| Q78470187 | The antiphospholipid syndrome |
| Q51814798 | The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V. |
| Q84845464 | The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms |
| Q73692134 | Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth |
| Q40490660 | Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome |
| Q28115185 | {beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome |
Search more.